Cargando…
Effects on Resource Utilization of Adding Salmeterol in Combination or Separately to Inhaled Corticosteroids
BACKGROUND: The addition of a long-acting beta-agonist (LABA) to an inhaled corticosteroid (ICS) for patients with moderate or severe persistent asthma improves outcomes such as pulmonary function, reduces exacerbations requiring oral steroids, and reduces use of rescue beta-agonists. OBJECTIVES: To...
Autores principales: | Chan, James, Hui, Rita L., Spence, Michele M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437375/ https://www.ncbi.nlm.nih.gov/pubmed/17269833 http://dx.doi.org/10.18553/jmcp.2007.13.1.21 |
Ejemplares similares
-
Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids
por: Hodder, Richard, et al.
Publicado: (2007) -
Administrative Claims Analysis of Asthma-Related Health Care Utilization for Patients Who Received Inhaled Corticosteroids With Either Montelukast or Salmeterol as Combination Therapy
por: Allen-Ramey, Felicia C., et al.
Publicado: (2006) -
Health Care Utilization Determined From Administrative Claims Analysis for Patients Who Received Inhaled Corticosteroids With Either Montelukast or Salmeterol
por: Markson, Leona E., et al.
Publicado: (2006) -
Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
por: Stanford, Richard H, et al.
Publicado: (2012) -
Uncovering the regional localization of inhaled salmeterol retention in the lung
por: Bäckström, Erica, et al.
Publicado: (2018)